MUMBAI : American private equity investor The Carlyle Group has agreed to acquire up to a 74% stake in animal health focused pharmaceutical company SeQuent Scientific Ltd, the company said in an exchange filing on Friday.
SeQuent is a pure-play animal healthcare company with global operations and provides active pharmaceutical ingredients (APIs), formulations, and analytical services in over 100 countries, with more than 1,700 employees and manufacturing operations in India, Spain, Turkey, Germany and Brazil.
Carlyle is acquiring a maximum of 183 million shares from the promoters and a mandatory open offer at Rs86 per share. The total consideration for the 74% stake will come to about Rs1,580 crore.